These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2. Thomas J, Ghosh A, Ranjan S, Satija J. Sci Rep; 2024 Apr 29; 14(1):9801. PubMed ID: 38684706 [Abstract] [Full Text] [Related]
7. Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2'-O-methyltransferase (nsp16) of SARS-CoV-2. Thomas J, Kumar S, Satija J. J Biomol Struct Dyn; 2024 Apr 29; 42(4):1999-2012. PubMed ID: 37129206 [Abstract] [Full Text] [Related]
9. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex. Khalili Yazdi A, Li F, Devkota K, Perveen S, Ghiabi P, Hajian T, Bolotokova A, Vedadi M. SLAS Discov; 2021 Jul 29; 26(6):757-765. PubMed ID: 33874769 [Abstract] [Full Text] [Related]
10. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2. Maurya AK, Mishra N. J Biomol Struct Dyn; 2021 Nov 29; 39(18):7306-7321. PubMed ID: 32835632 [Abstract] [Full Text] [Related]
12. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16. Klima M, Khalili Yazdi A, Li F, Chau I, Hajian T, Bolotokova A, Kaniskan HÜ, Han Y, Wang K, Li D, Luo M, Jin J, Boura E, Vedadi M. Protein Sci; 2022 Sep 29; 31(9):e4395. PubMed ID: 36040262 [Abstract] [Full Text] [Related]
13. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches. El Hassab MA, Ibrahim TM, Al-Rashood ST, Alharbi A, Eskandrani RO, Eldehna WM. J Enzyme Inhib Med Chem; 2021 Dec 29; 36(1):727-736. PubMed ID: 33685335 [Abstract] [Full Text] [Related]